AI Article Synopsis
- The study examines how interferon gamma release assay (IGRA) results change in Crohn's disease (CD) patients undergoing infliximab treatment in China, where tuberculosis (TB) is common.
- Out of 128 patients, 6.5% developed a positive IGRA after starting treatment, highlighting a potential risk for TB exposure, particularly in those with prior exposure.
- The findings suggest that IGRA monitoring should be increased early in infliximab treatment, and healthcare providers need to be vigilant about patients' TB exposure histories.
Article Abstract
Objective: To characterize the pattern of positive conversion of interferon gamma release assay (IGRA) in patients with Crohn's disease (CD) during infliximab therapy in China, which has a high burden of tuberculosis.
Methods: Eligible patients with CD who received serial IGRA screening during infliximab therapy from January 2015 to March 2020 were retrospectively included. The positive conversion rate of IGRA and the risk of subsequent tuberculosis of the patients were analyzed.
Results: A total of 128 patients with CD were included, and the median time from the initiation of IFX treatment to positive conversion or the last follow-up test of IGRA was 43.6 weeks. At baseline 3.9% of the patients were positive for IGRA and received prophylactic anti-tuberculosis treatment. In the other 123 patients with negative IGRA at baseline, 6.5% had IGRA positive conversion during infliximab treatment, and one (12.5%) who was exposed to Mycobacterium tuberculosis was diagnosed as having active tuberculosis. The conversion rate at 40 weeks, 2 years and 3 years after treatment were 10.0% (6/60), 2.2% (1/46) and 5.9% (1/17), respectively. Age, sex, history of smoking and alcohol consumption, disease severity (Crohn's disease activity index score) and immunosuppressive therapy were not significantly associated with latent tuberculosis test conversion.
Conclusions: Positive conversion of IGRA occurs early during treatment with infliximab for CD and the monitoring frequency of IGRA should be appropriately increased at the early stage of treatment. Physicians should pay attention to patient's history of tuberculosis exposure and carry out surveillance in a timely fashion.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1751-2980.13032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dual-signal portable microRNA biosensor based on a photothermal/visual strategy induced by cascading amplification techniques and horseradish peroxidase.
Talanta
January 2025
Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Key Laboratory of Analytical Science and Technology of Hebei Province, College of Chemistry and Materials Science, Hebei University, Baoding 071002, Hebei Province, PR China. Electronic address:
MicroRNAs (miRNAs) serve as potential biomarkers for many diseases such as cancer, neurodegenerative diseases and cardiovascular conditions. The portable and accurate detection of miRNA is of great significance for the early diagnosis, treatment optimization and prognostic evaluation of diseases. Herein, a photothermal/visual dual-mode assay for let-7a is developed utilizing oxidized 3, 3', 5, 5' - tetramethylbenzidine (oxTMB) as signal reporter.
View Article and Find Full Text PDFCS-QCFS: Bridging the performance gap in ultra-low latency spiking neural networks.
Neural Netw
January 2025
School of Electronic Science and Engineering, Nanjing University, Nanjing 210023, China.
Spiking Neural Networks (SNNs) are at the forefront of computational neuroscience, emulating the nuanced dynamics of biological systems. In the realm of SNN training methods, the conversion from ANNs to SNNs has generated significant interest due to its potential for creating energy-efficient and biologically plausible models. However, existing conversion methods often require long time-steps to ensure that the converted SNNs achieve performance comparable to the original ANNs.
View Article and Find Full Text PDFDynamic characteristics of high-risk HPV infection in women with low-grade cervical intraepithelial neoplasia, based on a community longitudinal study.
Eur J Clin Microbiol Infect Dis
January 2025
Department of Epidemiology, School of Public Health, Shanxi Medical University, 56, Xinjian Nan Road, Taiyuan, 030001, China.
Background: High-risk human papillomavirus (HR-HPV) infection is the primary cause of cervical cancer and precancerous lesions. Approximately 35% of women with low-grade cervical intraepithelial neoplasia (CIN1) may experience persistence or progression to high-grade lesions. Yet, the dynamic characteristics of HR-HPV infection in women with CIN1 remain unclear.
View Article and Find Full Text PDFHair isoniazid levels predict TB sputum culture conversion.
Int J Tuberc Lung Dis
January 2025
Department of Pharmacology and Therapeutics, Makerere College of Health Sciences, Kampala, Uganda.
Arginine as a multifunctional additive for high performance S-cathode.
ChemSusChem
January 2025
Washington State University, School of Mechanical and Materials Engineering, PO Box 642920, 99164-2920, Pullman, UNITED STATES OF AMERICA.
Advancement of sulfur (S) cathode of lithium-sulfur (Li-S) batteries is hindered by issues such as insulating nature of sulfur, sluggish redox kinetics, polysulfide dissolution and shuttling. To address these issues, we initiate a study on applying an important amino acid of protein, arginine (Arg), as a functional additive into S cathodes. Based on our simulation study, the positively charged Arg facilitates strong interactions with polysulfides.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!